National Library of Medicine Notice of Meeting, 80953-80954 [2011-33137]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 248 / Tuesday, December 27, 2011 / Notices
issues and on approaches that might be
considered for addressing the issues.
II. Criteria for Voting Members
Members and the Chair are selected
by the Commissioner or designee from
among individuals knowledgeable in
the fields of physical sciences,
biological and life science, food science,
risk assessment, nutrition, food
technology, molecular biology, and
other relevant scientific and technical
disciplines.
Members will be invited to serve for
terms of up to 4 years. The Committee
consists of 17 standing members; of that
15 are voting members, of whom 2 are
technically qualified members
identified with consumer interest. In
addition to the voting members the
Committee has 2 nonvoting members
who are identified with industry
interests.
III. Nomination Procedures
Any interested person may nominate
one or more qualified individuals for
membership on the advisory committee.
Self-nominations are also accepted.
Nominations must include a current,
´
´
complete resume or curriculum vitae for
each nominee, including current
business address and/or home address,
telephone number, and email address if
available. Nominations must also
specify the advisory committee for
which the nominee recommended.
Nominations must also acknowledge
that the nominee is aware of the
nomination unless self-nominated. FDA
will ask potential candidates to provide
detailed information concerning such
matters related to financial holdings,
employment, and research grants and/or
contracts to permit evaluation of
possible sources of conflicts of interest.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: December 20, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–33108 Filed 12–23–11; 8:45 am]
BILLING CODE 4160–01–P
sroberts on DSK5SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
hereby given of a meeting of the
National Advisory Dental and
Craniofacial Research Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: January 30, 2012.
Open: 8:30 a.m. to 11:15 a.m.
Agenda: Report to the Director, NIDCR.
Place: National Institutes of Health,
Building 31C, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 1 p.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31C, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Alicia J. Dombroski, PhD,
Director, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: December 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–33133 Filed 12–23–11; 8:45 am]
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
VerDate Mar<15>2010
22:00 Dec 23, 2011
Jkt 226001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
80953
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Center for Biotechnology Information.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for review, discussion, and evaluation of
individual intramural programs and
projects conducted by the National
Library of Medicine, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Center for
Biotechnology Information.
Date: April 17, 2012.
Open: 8:30 a.m. to 12 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Closed: 12 p.m. to 2 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Open: 2 p.m. to 3 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD,
Director, National Center of Biotechnology
Information, National Library of Medicine,
Department of Health and Human Services,
Building 38A, Room 8N805, Bethesda, MD
20892, (301) 435–5985,
dlipman@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
E:\FR\FM\27DEN1.SGM
27DEN1
80954
Federal Register / Vol. 76, No. 248 / Tuesday, December 27, 2011 / Notices
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS).
Dated: December 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Place: 6707 Democracy Boulevard,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Dr. Guillermo Arreaza,
Senior Advisor, Diabetes, Translation
Research, Division of Diabetes,
Endocrinology and Metabolic Diseases,
NIDDK, NIH, 6707 Democracy Boulevard,
Bethesda, MD 20892–5460, (301) 594–4724.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 98.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
[FR Doc. 2011–33137 Filed 12–23–11; 8:45 am]
Dated: December 20, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2011–33136 Filed 12–23–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.) notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for type 1
diabetes. The outcome of the evaluation
will be a decision whether NIDDK
should support the request and make
available contract resources for
development of the potential
therapeutic to improve the treatment or
prevent the development of type 1
diabetes and its complications. The
research proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the proposed research
projects, the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
sroberts on DSK5SPTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Disorders;
Notice of Closed Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Interagency Breast Cancer and
Environmental Research Coordinating
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
National Institute of Environmental
Health Sciences; Notice of Meeting
Name of Committee: Type 1 Diabetes—
Rapid Access to Intervention Development
Special Emphasis Panel, National Institute of
Diabetes and Digestive and Kidney Diseases.
Date: January 26, 2012.
Time: 3 p.m.–5 p.m.
Agenda: To evaluate requests for
preclinical development resources for
potential new therapeutics for type 1 diabetes
and its complications.
VerDate Mar<15>2010
22:00 Dec 23, 2011
Jkt 226001
Name of Committee: Interagency Breast
Cancer and Environmental Research
Coordinating Committee.
Date: January 4, 2012.
Time: 1 p.m. to 3 p.m.
Agenda: The purpose of the meeting is to
continue the work of the Research Process
Subcommittee as it addresses a broad set of
objectives related to the overall mandate of
the IBCERC including: setting research
priorities, decreasing redundancies across
federal and non-governmental organizations,
developing a process for soliciting research,
fostering collaborations, highlighting peer
review issues, and identifying the most
appropriate models for agencies to work
together. The meeting agenda will be
available on the Web at https://
www.niehs.nih.gov/about/orgstructure/
boards/ibcercc/.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709, (Conference Call:
This meeting will be conducted remotely, via
conference call. To attend the meeting, please
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
RSVP via email to ibcercc@niehs.nih.gov at
least 10 days in advance and instructions for
joining the meeting will be provided.)
Contact Person: Gwen W. Collman, Ph.D.,
Director, Division of Extramural Research
and Training, Nat. Inst. of Environmental
Health Sciences, National Institutes of
Health, 615 Davis Dr., KEY615/3112,
Research Triangle Park, NC 27709, (919) 541–
4980, collman@niehs.nih.gov .
Any member of the public interested in
presenting oral comments to the committee
should submit their remarks in writing at
least 10 days in advance of the meeting.
Comments in document format (i.e. WORD,
Rich Text, PDF) may be submitted via email
to ibcercc@niehs.nih.gov or mailed to the
Contact Person listed on this notice. You do
not need to attend the meeting in order to
submit comments.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: December 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–33138 Filed 12–23–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Hearing and Pain.
Date: January 17–18, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 76, Number 248 (Tuesday, December 27, 2011)]
[Notices]
[Pages 80953-80954]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33137]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of a meeting of the
Board of Scientific Counselors, National Center for Biotechnology
Information.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for review, discussion, and evaluation of individual
intramural programs and projects conducted by the National Library of
Medicine, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, National
Center for Biotechnology Information.
Date: April 17, 2012.
Open: 8:30 a.m. to 12 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20892.
Closed: 12 p.m. to 2 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20892.
Open: 2 p.m. to 3 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD, Director, National Center
of Biotechnology Information, National Library of Medicine,
Department of Health and Human Services, Building 38A, Room 8N805,
Bethesda, MD 20892, (301) 435-5985, dlipman@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
[[Page 80954]]
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program No. 93.879,
Medical Library Assistance, National Institutes of Health, HHS).
Dated: December 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-33137 Filed 12-23-11; 8:45 am]
BILLING CODE 4140-01-P
